Precision Medicine Group

Precision Medicine Group, founded in 2012, provides integrated, mission-critical services for pharmaceutical and life-sciences companies. The firm specializes in advanced lab sciences, translational informatics, regulatory affairs, payer insights, and strategic marketing communications. By bridging the gap between clinical development and market access, the company supports global clients in navigating complex regulatory environments and optimizing product launch trajectories. Their expertise ensures that biopharmaceutical innovations are effectively translated into viable commercial solutions for patients worldwide.

Operating with 1,000-5,000 employees across 2 locations, the organization maintains a robust infrastructure to support complex drug development and biopharmaceutical projects. Their multidisciplinary team of experts delivers specialized consulting and technical services designed to accelerate the path from laboratory identification to patient delivery. Meet Precision Medicine Group's team to learn about their leadership, organizational structure, and the technical expertise driving their operational success in the life sciences sector.

The company has secured significant capital through multiple funding rounds, including private equity and debt financing from major investors such as TPG Capital and Morgan Stanley. With annual revenue reaching $949.5M, Precision Medicine Group remains a highly competitive player in the management consulting and business services sector, rivaling established firms like Premier Research, Crown Bioscience, and QPS. Explore financial highlights for detailed metrics regarding their historical growth, funding history, and current market performance within the global biopharmaceutical landscape.